North America Beta-Glucan Market

North America Beta-Glucan Market Size

The North America Beta-Glucan Market size was calculated to be USD 130.96 million in 2024 and is anticipated to be worth USD 249.19 million by 2033, from USD 140.66 million in 2025, growing at a CAGR of 7.41% during the forecast period.

Beta-glucan is a naturally occurring polysaccharide found in the cell walls of yeast, fungi, algae, lichens, and certain grains such as oats and barley. It is known for its immune-modulating properties, and beta-glucans have gained significant attention across the health, nutrition, pharmaceuticals, and cosmetics sectors.

Also, rising consumer awareness about preventive healthcare, increasing demand for functional foods, and growing applications in dermatology and biopharmaceuticals have collectively driven market expansion in North America.

In addition to human health, beta-glucans are increasingly utilized in animal feed formulations to enhance immunity and reduce reliance on antibiotics. The U.S. Department of Agriculture (USDA) has acknowledged the potential of beta glucan-based feed additives in promoting sustainable livestock production. Similarly, Canada has also seen a surge in demand for natural ingredients in personal care products, further bolstering the market. As scientific research continues to validate the benefits of beta-glucans—from cardiovascular health to skin rejuvenation—their integration into a wide range of commercial products is accelerating.

MARKET DRIVERS

Rising Demand for Immune-Boosting Dietary Supplements

The surging demand for immune-boosting dietary supplements, particularly in the wake of heightened global health concerns, is a primary driver of the North American beta-glucan market Consumers are increasingly turning to natural ingredients that offer proven immunomodulatory effects, and beta-glucans—especially those derived from yeast and mushrooms—have emerged as a preferred choice. This trend is reinforced by clinical studies demonstrating beta glucan’s ability to activate macrophages and enhance natural killer cell activity, thereby strengthening the body's defense mechanisms. Institutions such as the National Institutes of Health (NIH) have funded multiple trials examining beta glucan’s role in reducing upper respiratory tract infections and post-surgical recovery times.

Additionally, leading supplement manufacturers like NOW Foods and Jarrow Formulas have incorporated beta-glucans into their product lines, often marketing them alongside vitamin C and zinc for synergistic immune support.

Moreover, digital health platforms and wellness influencers have played a crucial role in educating consumers about the benefits of immune-enhancing nutrients. This growing awareness, coupled with an aging population seeking preventative health solutions, continues to drive robust growth in the North America beta glucan market.

Expansion of Functional Food and Beverage Applications

The incorporation of beta-glucans into functional foods and beverages is another key driver fueling the North American beta-glucan market. Consumers are increasingly prioritizing nutrient-dense food options that offer health benefits beyond basic nutrition, prompting food and beverage companies to fortify products with bioactive compounds like beta-glucans. As per data from the International Food Information Council (IFIC), more than 60% of surveyed consumers in 2023 indicated they were actively seeking out foods with added health benefits, including immune support and heart health.

Oat-derived beta glucans have been extensively used in breakfast cereals, dairy alternatives, snack bars, and bakery items due to their well-established cholesterol-lowering effects. The U.S. Food and Drug Administration (FDA) recognizes oat beta glucan as a heart-healthy ingredient, allowing approved health claims on product labels—a factor that has significantly influenced purchasing decisions. Companies such as General Mills and Quaker Oats have leveraged this endorsement to market heart-healthy grain-based products.

Beyond traditional foods, plant-based and fortified beverages have also embraced beta glucan supplementation to cater to health-conscious consumers. These developments reflect a broader shift toward proactive wellness and position beta-glucans as a cornerstone ingredient in the evolving functional food landscape of North America.

MARKET RESTRAINTS

Limited Clinical Consensus on Efficacy Across All Forms of Beta Glucan

A major restraint affecting the North American market is the lack of uniform clinical consensus regarding their efficacy across different forms and sources. While yeast-derived beta-glucans have demonstrated consistent immune-stimulatory effects in peer-reviewed studies, other variants—such as those extracted from mushrooms or grains—exhibit variable molecular structures and biological activities. According to a 2023 review published in Nutrients, inconsistencies in clinical trial outcomes have made it challenging to establish standardized dosing guidelines and therapeutic claims across all beta glucan types.

Regulatory bodies such as the U.S. Food and Drug Administration (FDA) and Health Canada require substantial clinical evidence before endorsing specific health benefits, which has led to cautious labeling practices. Some manufacturers face hurdles in substantiating broad-spectrum immune claims without conclusive, large-scale human trials. This uncertainty can deter both consumers and healthcare professionals from fully embracing beta glucan-containing products, especially in pharmaceutical and medical nutrition contexts.

In addition, misinformation circulating on digital platforms has created confusion among end users regarding which forms of beta-glucan are most effective.

Regulatory Hurdles and Labeling Restrictions

Regulatory constraints are a serious barrier to the growth of the North American beta-glucan market, particularly concerning health claims and product categorization. While beta-glucans are widely available in dietary supplements, functional foods, and cosmetics, regulatory agencies impose strict limitations on how these products can be marketed. In line with the U.S. Food and Drug Administration (FDA), unless a specific beta glucan variant receives drug approval status, manufacturers cannot make direct disease prevention or treatment claims on packaging or promotional materials.

This restriction limits consumer awareness and hinders differentiation among competing products. For instance, while oat beta-glucan is permitted to carry heart health claims under FDA-approved guidelines, yeast-derived versions do not enjoy the same level of endorsement, even though research supports their immune-modulating benefits. Similarly, Health Canada maintains stringent criteria for natural health products, requiring extensive documentation before approving any therapeutic assertions.

These regulatory complexities create challenges for smaller companies attempting to enter the market, as compliance costs can be prohibitively high. Moreover, inconsistent international standards complicate export opportunities and limit harmonization across North America.

MARKET OPPORTUNITIES

Increasing Use in Cosmetics and Personal Care Products

The growing adoption of beta-glucans within the cosmetics and personal care industry presents an expanding opportunity for the North American beta-glucan market. Consumers are increasingly seeking skincare products that offer more than just hydration—demanding ingredients with scientifically backed benefits such as anti-inflammatory, antioxidant, and wound-healing properties. Beta-glucans, particularly those derived from yeast and oats, have demonstrated effectiveness in improving skin texture, enhancing moisture retention, and supporting skin barrier function.

Leading beauty brands such as L’Oréal, Estée Lauder, and Paula’s Choice have integrated beta glucan into serums, moisturizers, and post-procedure skincare regimens targeting sensitive and aging skin. The compound’s ability to soothe irritation and accelerate tissue repair makes it particularly valuable in formulations designed for acne-prone, eczema-afflicted, or post-laser treatment skin.

Additionally, clean beauty trends and the demand for plant-based ingredients align well with beta glucan’s natural origin and biocompatibility. As consumers become more discerning about ingredient transparency and efficacy, beta glucan-infused products are gaining traction across premium and mass-market segments alike, offering substantial growth potential for market players in North America.

Growing Applications in Animal Feed and Livestock Health Management The next promising opportunity for the North American beta-glucan market is its expanding use in animal feed and livestock health management. With increasing scrutiny on antibiotic use in agriculture due to concerns over antimicrobial resistance, there is a growing shift toward natural alternatives that support animal immunity and overall health. Beta-glucans, particularly yeast-derived varieties, have demonstrated immunostimulatory effects in poultry, swine, and aquaculture, making them attractive candidates for inclusion in feed formulations.

As indicated by U.S. Department of Agriculture (USDA), a significant portion of livestock producers surveyed in 2023 were exploring non-antibiotic feed additives to improve disease resistance and productivity. Beta glucans have been shown to enhance gut health, reduce pathogen colonization, and improve vaccine response in animals, contributing to lower mortality rates and higher yields.

Top agricultural companies such as Cargill and ADM have introduced beta glucan-enriched feed supplements aimed at supporting sustainable farming practices. Universities and research institutions—including Cornell University and Iowa State University—are conducting studies to optimize dosage levels and delivery methods for different species.

MARKET CHALLENGES

Source Variability and Standardization Issues

One of the foremost challenges facing the North American beta-glucan market is the variability in source materials and the lack of standardized testing protocols, which can impact product consistency and efficacy. Beta-glucans are extracted from diverse sources such as yeast, oats, mushrooms, and algae, each with distinct molecular structures, chain lengths, and branching patterns that influence their biological activity. As noted by the American Herbal Products Association (AHPA), differences in sourcing and processing methods can lead to variations in purity and potency, making it difficult for manufacturers to guarantee uniform quality across batches.

Furthermore, the absence of universally accepted analytical standards complicates regulatory compliance and consumer trust. Unlike pharmaceuticals, where active ingredients must meet strict identification and quantification criteria, dietary supplements containing beta-glucans often rely on proprietary methods for content verification. This inconsistency can result in misleading labeling and diminished consumer confidence, particularly among healthcare professionals recommending these products for immune support.

Consumer Misunderstanding and Confusion Regarding Product Claims

Consumer misunderstanding and confusion regarding beta glucan product claims present a significant challenge in the North American market. Despite growing awareness of immune health, many consumers remain uncertain about the distinctions between different-glucan sources, their mechanisms of action, and their respective benefits.

Compounding the issue is the proliferation of exaggerated or loosely regulated marketing statements, particularly in the dietary supplement sector. While some brands emphasize broad immune-boosting properties without specifying the type or dosage of beta-glucan used, others make unsubstantiated claims about disease prevention, creating skepticism among informed consumers and healthcare providers. According to the U.S. Federal Trade Commission (FTC), enforcement actions against misleading supplement advertising have increased in recent years, highlighting the need for clearer communication around beta glucan functionality.

Educational initiatives and improved labeling clarity are essential to building trust and ensuring that consumers can make well-informed choices.

REPORT COVERAGE

SEGMENTAL ANALYSIS

By Category Insights

Soluble beta glucan secured the largest share in the North America beta glucan market i.e. 63.4% of total revenue in 2024. This dominance is primarily driven by its widespread use in functional foods, dietary supplements, and pharmaceutical formulations due to its proven health benefits, particularly in cardiovascular and immune support.

One key driver behind this segment’s prowess is the well-documented cholesterol-lowering effect of soluble beta-glucans derived from oats and barley. According to the U.S. Food and Drug Administration (FDA), products containing at least 3 grams of beta-glucan fiber per serving can carry heart health claims, which has significantly influenced consumer purchasing behavior.

Additionally, soluble beta-glucan is extensively used in immune-boosting dietary supplements, particularly those sourced from yeast.

Insoluble beta glucan is becoming the swiftest growing category in the North America beta glucan market, projected to grow at a CAGR of 7.2%. Unlike its soluble counterpart, insoluble beta glucan—primarily derived from fungal and yeast sources—is gaining traction for its potent immunomodulatory properties and applications in dermatology and biopharmaceuticals.

A major factor driving this growth is the increasing utilization of insoluble beta-glucan in skin care and wound healing products. Research published in the Journal of Cosmetic Dermatology highlights its efficacy in accelerating skin regeneration, reducing inflammation, and strengthening epidermal barrier function. Leading cosmetic brands such as L’Oréal and Neutrogena have incorporated insolublebeta-glucann into anti-aging creams, post-procedure treatments, and sensitive-skin formulations, contributing to heightened consumer interest in natural, science-backed ingredients. Furthermore, its role in oncology and infectious disease management is gaining attention.

By Application Insights

The healthcare and dietary supplements segment commanded the North American beta-glucan market, capturing 55.1% of total revenue in 2024. This leading position is supported by the growing consumer focus on preventive healthcare, immune system enhancement, and overall wellness, particularly in the wake of global health concerns.

Beta glucan, especially yeast-derived variants, has been widely incorporated into immune-boosting formulations due to its scientifically validated ability to activate macrophages and stimulate natural killer cell activity. Companies like NOW Foods, Nature's Way, and Jarrow Formulas have integrated beta glucan into their product lines, often marketing them alongside vitamin D and zinc for synergistic effects.

Moreover, clinical research funded by the National Institutes of Health (NIH) has reinforced the role of beta glucan in enhancing vaccine efficacy and reducing susceptibility to respiratory infections. These findings have further bolstered consumer confidence and encouraged healthcare professionals to recommend beta glucan-containing supplements.

The food and beverage application segment is estimated to be the rapidly advancing section in the North American beta-glucan market, exhibiting a CAGR of 6.9%. This quick growth is fueled by rising demand for functional foods that offer health benefits beyond basic nutrition, particularly in supporting heart health and immune function.

Oat-derived beta glucan has been at the forefront of this trend due to its FDA-approved heart health claim, allowing manufacturers to promote cholesterol-lowering benefits on packaging. Brands such as Quaker Oats and General Mills have leveraged this endorsement to expand their heart-healthy product portfolios, appealing to health-conscious consumers.

Beyond traditional grain-based applications, plant-based and fortified beverages are also adopting beta glucan to meet growing demand for immunity-enhancing ingredients.

By Source Insights

Cereals, particularly oats and barley, prevailed in the North America beta glucan market, holding a 48.9% of total market share in 2024. This superiority is mainly credited to the extensive use of cereal-derived beta glucans in functional foods, heart-healthy claims, and dietary supplements backed by regulatory endorsements.

Also, the clean-label movement and consumer preference for whole grains have further strengthened the appeal of cereal-based beta-glucan. Companies such as Quaker Oats and ADM have launched oat fiber concentrates and beta-glucan isolates specifically designed for food fortification. Given the strong alignment with public health messaging and the versatility of cereal sources in both food and supplement formats, this segment continues to lead the North American beta-glucan market.

Yeast-derived beta glucan is identified as the fastest-growing source segment in the North America beta glucan market, with a projected CAGR of 8.1%. This is primarily driven by its superior biological activity and expanding applications in dietary supplements, cosmetics, and biopharmaceuticals.

Unlike cereal-based beta glucans, yeast-derived variants exhibit a highly branched structure that enhances immune stimulation by activating macrophages and modulating cytokine responses. According to a 2023 review published in Frontiers in Immunology, yeast beta glucan has demonstrated significant potential in improving resistance against viral and bacterial infections, making it a favored ingredient in immune-boosting formulations.

This segment has also gained traction in the skincare industry due to its anti-inflammatory and skin-repairing properties. Leading beauty companies such as Estée Lauder and Paula’s Choice have introduced serums and moisturizers containing yeast beta-glucan to address conditions like eczema, rosacea, and post-procedural skin damage.

REGIONAL ANALYSIS

The United States had the dominant position in the North American beta-glucan market, commanding 70.1% of total regional revenue in 2024. This is primarily attributable to the country’s robust health and wellness industry, strong presence of key manufacturers, and high consumer awareness regarding immune health and functional nutrition.

The U.S. Food and Drug Administration (FDA) has played a pivotal role in shaping market dynamics by approving heart health claims for oat-derived beta-glucan, thereby influencing product development and consumer trust.

In addition, the U.S. functional food and beverage sector has embraced beta glucan fortification, particularly in oat-based products marketed for cardiovascular benefits. Companies such as Quaker Oats, General Mills, and Nestlé have expanded their offerings to include beta glucan-enriched cereals, bars, and dairy alternatives. Furthermore, leading cosmetic brands like L’Oréal and Neutrogena have incorporated yeast-derived beta glucan into skincare regimens targeting skin repair and immune modulation.

Canada is positioning itself as the second-largest contributor in the region. This market position is supported by increasing government initiatives promoting functional foods, rising consumer interest in natural health products, and expanding applications in personal care and animal feed sectors.

Beta glucan-based supplements have gained popularity among health-conscious consumers seeking preventative wellness solutions. Health Canada’s Natural and Non-Prescription Health Products Directorate (NNHPD) has facilitated market access by allowing certain immune-related claims under approved guidelines, encouraging manufacturers to introduce new formulations tailored to local preferences.

Also, Canada’s burgeoning plant-based food industry has contributed to the increased incorporation of beta-glucan into fortified foods and beverages. Domestic and international brands alike are leveraging consumer demand for clean-label, heart-healthy ingredients to expand product portfolios. Moreover, academic institutions such as the University of Manitoba have researched cereal beta-glucans, reinforcing their role in metabolic and cardiovascular health.

The Rest of North America, comprising Mexico and select Caribbean territories, represents a smaller but rapidly evolving segment of the beta-glucan market. While historically overshadowed by the U.S. and Canada, this segment is witnessing increased interest in immune-boosting ingredients, particularly within the dietary supplement and functional food sectors.

Mexico, in particular, has seen a surge in demand for natural health products, driven by rising disposable incomes and greater awareness of preventive healthcare.

Additionally, the country’s agricultural sector has begun exploring beta glucan-enriched animal feed additives to support livestock immunity amid growing concerns over antibiotic resistance. Institutions such as the National Institute of Forestry, Agricultural, and Livestock Research (INIFAP) have initiated studies on yeast beta glucan applications in poultry and swine farming, aligning with global sustainability trends.

LEADING PLAYERS IN THE NEW AMERICAN BBETAGLUCAN MARKET

NutriForce Sports, Inc.

NutriForce Sports is a leading player in the North America beta glucan market, known for its premium sports nutrition and immune health products. The company has significantly contributed to the global market by integrating high-quality beta glucan into performance-enhancing supplements. Their commitment to research and development ensures product efficacy, which has helped expand consumer trust and market reach.

Wellmune, Inc.

Wellmune is a major innovator in the beta-glucan space, offering science-backed immune health ingredients used across dietary supplements, functional foods, and beverages. Its flagship product, Wellmune® beta-glucan, is widely adopted globally, setting industry benchmarks for quality and effectiveness. Through strategic partnerships and education initiatives, Wellmune strengthens both consumer awareness and supply chain integration.

Fytexia, Inc.

Fytexia specializes in natural ingredient solutions, with beta glucan being a key component of its portfolio. The company contributes to the global market by providing clean-label, plant-based formulations that cater to health-conscious consumers. Fytexia’s focus on sustainability and innovation supports the growing demand for functional ingredients in food, beverage, and pharmaceutical sectors across North America and beyond.

TOP STRATEGIES USED BY KEY MARKET PARTICIPANTS

Key players in the North American beta-glucan market utilize several strategies to solidify their market positions. One major approach is product innovation, where companies invest in developing new formulations and delivery formats such as gummies, powders, and fortified beverages to meet evolving consumer preferences. Another strategy is strategic partnerships including collaborations with research institutions and co-branding with established wellness brands to enhance credibility and market visibility. Lastly, market education initiatives play a crucial role, as companies actively engage in promoting clinical studies and hosting webinars to inform healthcare professionals and consumers about the benefits of beta-glucan thereby driving demand and brand loyalty.

KEY MARKET PLAYERS AND COMPETITION OVERVIEW

Major Players in the North America Beta Glucan Market include Associated British Foods Plc, Groupe Soufflet S.A, Tate & Lyle plc, Zilor Inc. (Biorigin), Biotec Pharmacon ASA (Biotec BetaGlucans AS), Biothera the Immune Health Company, Ceapro Inc, Immuno Medic AS, Koninklijke DSM N.V, and Super Beta Glucan (SBG) Inc.

The competition in the North American beta-glucan market is intensifying as more companies recognize the growing consumer interest in immune support and overall wellness. Established players are leveraging their strong distribution networks and brand equity to maintain dominance while emerging firms are focusing on niche segments and innovative product offerings to carve out market share. The presence of multiple ingredient suppliers, contract manufacturers, and end-product developers creates a dynamic landscape where differentiation through quality, formulation, and marketing becomes essential. Companies are also competing based on sourcing transparency, sustainability practices, and certifications that appeal to health-conscious consumers. With rising demand from the dietary supplement, functional food, and pharmaceutical sectors, firms are continuously adapting their strategies to stay ahead. Collaborations, acquisitions, and targeted marketing campaigns have become common tactics to enhance visibility and capture new customer bases in this highly competitive environment.

RECENT HAPPENINGS IN THE MARKET

• In March 2024, Wellmune launched an educational campaign targeting healthcare practitioners to increase awareness of the immune benefits of beta-glucan, aiming to boost professional endorsements and consumer trust.
• In June 2024, NutriForce Sports introduced a line of beta glucan-infused sports recovery gummies, catering to athletes seeking immunity support alongside muscle recovery.
• In September 2024, Fytexia partnered with a major plant-based beverage brand to integrate its beta-glucan into a new line of functional drinks aimed at enhancing daily immunity.
• In November 2024, a leading natural ingredient distributor expanded its portfolio by signing exclusive supply agreements with two European beta glucan producers to ensure high-quality raw material access.
• In February 2025, a prominent nutraceutical firm acquired a small biotech startup specializing in yeast-derived beta glucan technology to enhance its R&D capabilities and product differentiation.

DETAILED SEGMENTATION OF THE NORTH AMERICA BETA GLUCAN MARKET INCLUDED IN THIS REPORT

This research report on the North American beta Glucan Market has been segmented and sub-segmented based on category, application, source & region.

By Category

• Soluble Beta Glucan
• Insoluble Beta Glucan

By Application

• Healthcare and Dietary Supplements
• Food and Beverage Applications

By Source

• Cereals (Oats and Barley)
• Yeast-Derived Beta Glucan

By Region

• US
• Canada
• Mexico
• Rest of North America